Discover
ANIP
ANI Pharmaceuticals, Inc.
72.00
2 x 56.91
2 x 103.53
bid
ask
-
1.16
1.59%
2 @ 04:00 PM
72.00 +0.00 (0.00%)
| Ytd | -8.79% | |
| 1y | -21.68% |
71.90
day range
73.54
69.58
52 week range
95.57
| Open | 73.27 | Prev Close | 73.16 | Low | 71.90 | High | 73.54 | Mkt Cap | 1.65B |
| Vol | 286.87K | Avg Vol | 386.57K | EPS | 4.62 | P/E | 15.58 | Forward P/E | 7.14 |
| Beta | 0.49 | Short Ratio | 8.21 | Inst. Own | 107.18% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-05 | 50-d Avg | 73.06 | 200-d Avg | 77.72 | 1yr Est | 105.78 |
Earning
| Date | For | Estimate | Reported | Surprise | surprise % |
|---|---|---|---|---|---|
| 2026-11-05 | 2026-09 | 2.18 | N/A | N/A | N/A |
| 2026-08-07 | 2026-06 | 2.04 | 2.21 | 0.17 | 8.33% |
| 2026-05-08 | 2026-03 | 1.28 | 2.05 | 0.77 | 60.16% |
| 2026-02-27 | 2025-12 | 1.99 | 2.33 | 0.34 | 17.09% |
| 2025-11-07 | 2025-09 | 1.74 | 2.04 | 0.3 | 17.24% |
| 2025-08-08 | 2025-06 | 1.38 | 1.8 | 0.42 | 30.43% |
Upgrade / Downgrade
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| 2026-09-23 | Oppenheimer | Upgrade | Perform | |
| 2026-08-10 | Guggenheim | Upgrade | Buy | Buy |
| 2026-08-10 | Canaccord Genuity | Upgrade | Hold | Hold |
| 2026-07-17 | Canaccord Genuity | Upgrade | Hold | |
| 2026-07-10 | Guggenheim | Upgrade | Buy | Buy |
| 2026-01-16 | Guggenheim | Upgrade | Buy | Buy |
Profile
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products. It also manufactures oral solid dose products, semi-solids, liquids, topicals, controlled substances, and potent products. The company serves its products to national wholesalers, specialty pharmacies, retail pharmacy chains, distributors, mail order houses, group purchasing organizations, and hospitals and healthcare providers. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.
Insider Holder
| Date | Name | Relation | Quantity | Description |
|---|---|---|---|---|
| 2026-09-28 | CAREY STEPHEN P. | Chief Financial Officer | 168.99K | Sale |
| 2026-10-12 | COOK MEREDITH | General Counsel | 73.42K | Sale |
| 2026-03-08 | DAVIS KRISTA | Officer | 51.95K | Sale |
| 2026-02-25 | GASSERT CHAD | Officer | 233.41K | Stock Award(Grant) |
| 2026-08-09 | GUTWERG ORI | Officer | 75.53K | Sale |
| 2026-06-07 | HAUGHEY THOMAS J | Director | 38.88K | Sale |
Institution Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2026-06-29 | Blackrock Inc. | 2.96M | 213.92M | 12.89% |
| 2026-06-29 | Soleus Capital Management, L.P. | 867.76K | 62.74M | 3.78% |
| 2026-06-29 | Vanguard Capital Management LLC | 838.22K | 60.61M | 3.65% |
| 2026-06-29 | State Street Corporation | 831.65K | 60.13M | 3.62% |
| 2026-06-29 | Tang Capital Management, LLC | 707.50K | 51.16M | 3.08% |
| 2026-06-29 | Dimensional Fund Advisors LP | 623.46K | 45.08M | 2.72% |
Fund Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2026-09-29 | iShares Trust-iShares Core S&P Small-Cap ETF | 1.20M | 86.67M | 5.22% |
| 2026-09-29 | American Century ETF Trust-Avantis U.S. Small Cap Value ETF | 745.30K | 53.89M | 3.25% |
| 2026-06-29 | VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 609.43K | 44.07M | 2.65% |
| 2026-09-29 | iShares Trust-iShares Russell 2000 ETF | 529.88K | 38.31M | 2.31% |
| 2026-06-29 | OBERWEIS FUNDS-Oberweis Micro-Cap Fund | 256.30K | 18.53M | 1.12% |
| 2026-07-30 | Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 224.19K | 16.21M | 0.98% |
Split
| Split | Date |
|---|---|
| 0.16667 : 1 | 2013-07-18 |
| 0.16667 : 1 | 2012-06-04 |
| 0.1 : 1 | 2002-06-03 |